These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 23509325

  • 21. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP.
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [Abstract] [Full Text] [Related]

  • 22. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP.
    Blood; 1996 Nov 15; 88(10):3926-36. PubMed ID: 8916959
    [Abstract] [Full Text] [Related]

  • 23. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR.
    Caprodossi S, Pedinotti M, Amantini C, Santoni G, Minucci S, Pelicci PG, Fanelli M.
    Mol Biotechnol; 2005 Jul 15; 30(3):231-8. PubMed ID: 15988048
    [Abstract] [Full Text] [Related]

  • 24. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.
    Nature; 1998 Feb 19; 391(6669):815-8. PubMed ID: 9486655
    [Abstract] [Full Text] [Related]

  • 25. Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure.
    de Thé H, Pandolfi PP, Chen Z.
    Cancer Cell; 2017 Nov 13; 32(5):552-560. PubMed ID: 29136503
    [Abstract] [Full Text] [Related]

  • 26. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
    Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, Bernasconi P, Di Raimondo F, Stanghellini MT, Marco P, Mays AN, Döhner H, Sanz MA, Amadori S, Grimwade D, Lo-Coco F.
    Genes Chromosomes Cancer; 2010 Aug 13; 49(8):726-32. PubMed ID: 20544846
    [Abstract] [Full Text] [Related]

  • 27. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X.
    Chin Med J (Engl); 2001 Jan 13; 114(1):30-4. PubMed ID: 11779431
    [Abstract] [Full Text] [Related]

  • 28. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
    Lång E, Grudic A, Pankiv S, Bruserud O, Simonsen A, Bjerkvig R, Bjørås M, Bøe SO.
    Blood; 2012 Jul 26; 120(4):847-57. PubMed ID: 22692509
    [Abstract] [Full Text] [Related]

  • 29. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
    Giannì M, de Thé H.
    Leukemia; 1999 May 26; 13(5):739-49. PubMed ID: 10374879
    [Abstract] [Full Text] [Related]

  • 30. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T, Kimura F, Nakata Y, Sato K, Ogura K, Motoyoshi K, Sporn M, Kufe D.
    Cell Death Differ; 2005 May 26; 12(5):523-31. PubMed ID: 15746941
    [Abstract] [Full Text] [Related]

  • 31. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW, Wang P, Liu JQ, Zhang H, Xi WD, Jia XH, Wang KK.
    Oncogene; 2014 May 22; 33(21):2700-8. PubMed ID: 23770850
    [Abstract] [Full Text] [Related]

  • 32. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D, Solomon E.
    Curr Top Microbiol Immunol; 1997 May 22; 220():81-112. PubMed ID: 9103677
    [Abstract] [Full Text] [Related]

  • 33. Acute Promyelocytic Leukemia, Retinoic Acid, and Arsenic: A Tale of Dualities.
    Rérolle D, Wu HC, de Thé H.
    Cold Spring Harb Perspect Med; 2024 Sep 03; 14(9):. PubMed ID: 38503502
    [Abstract] [Full Text] [Related]

  • 34. The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.
    de Thé H, Le Bras M, Lallemand-Breitenbach V.
    J Cell Biol; 2012 Jul 09; 198(1):11-21. PubMed ID: 22778276
    [Abstract] [Full Text] [Related]

  • 35. Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.
    Osumi T, Tsujimoto SI, Tamura M, Uchiyama M, Nakabayashi K, Okamura K, Yoshida M, Tomizawa D, Watanabe A, Takahashi H, Hori T, Yamamoto S, Hamamoto K, Migita M, Ogata-Kawata H, Uchiyama T, Kizawa H, Ueno-Yokohata H, Shirai R, Seki M, Ohki K, Takita J, Inukai T, Ogawa S, Kitamura T, Matsumoto K, Hata K, Kiyokawa N, Goyama S, Kato M.
    Cancer Res; 2018 Aug 15; 78(16):4452-4458. PubMed ID: 29921692
    [Abstract] [Full Text] [Related]

  • 36. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.
    Oncogene; 2006 Mar 23; 25(13):1974-9. PubMed ID: 16331271
    [Abstract] [Full Text] [Related]

  • 37. The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia.
    Nagai S, Takahashi T, Kurokawa M.
    Curr Stem Cell Res Ther; 2010 Dec 23; 5(4):372-8. PubMed ID: 20528759
    [Abstract] [Full Text] [Related]

  • 38. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.
    Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2551-6. PubMed ID: 9122233
    [Abstract] [Full Text] [Related]

  • 39. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
    Yang S, Jeong JH, Brown AL, Lee CH, Pandolfi PP, Chung JH, Kim MK.
    J Biol Chem; 2006 Sep 08; 281(36):26645-54. PubMed ID: 16835227
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein.
    Ng AP, Nin DS, Fong JH, Venkataraman D, Chen CS, Khan M.
    Mol Cancer Ther; 2007 Aug 08; 6(8):2240-8. PubMed ID: 17699721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.